tiprankstipranks
Advertisement
Advertisement
Ono Pharmaceutical’s Phase 3 Trial: A New Hope for PCNSL Treatment
PremiumCompany AnnouncementsOno Pharmaceutical’s Phase 3 Trial: A New Hope for PCNSL Treatment
5M ago
Ono Pharmaceutical’s ONO-1110: A Promising Study for Interstitial Cystitis
Premium
Company Announcements
Ono Pharmaceutical’s ONO-1110: A Promising Study for Interstitial Cystitis
5M ago
ONO Pharmaceutical Advances Fibromyalgia Treatment with ONO-1110 Study
Premium
Company Announcements
ONO Pharmaceutical Advances Fibromyalgia Treatment with ONO-1110 Study
5M ago
ONO Pharmaceutical’s ONO-2020: A Promising Alzheimer’s Study Update
PremiumCompany AnnouncementsONO Pharmaceutical’s ONO-2020: A Promising Alzheimer’s Study Update
5M ago
ONO Pharmaceutical’s Phase III Study on Cenobamate: A Potential Game-Changer for Epilepsy Treatment
Premium
Company Announcements
ONO Pharmaceutical’s Phase III Study on Cenobamate: A Potential Game-Changer for Epilepsy Treatment
5M ago
Ono Pharmaceutical’s ONO-4538 Study: A Closer Look at Its Market Potential
Premium
Company Announcements
Ono Pharmaceutical’s ONO-4538 Study: A Closer Look at Its Market Potential
5M ago
ONO Pharmaceutical’s ONO-4685: A Promising Phase I Study in T Cell Lymphoma and CLL/SLL
PremiumCompany AnnouncementsONO Pharmaceutical’s ONO-4685: A Promising Phase I Study in T Cell Lymphoma and CLL/SLL
5M ago
Ono Pharmaceutical’s ONO-1110: A Promising Study for Social Anxiety Disorder
Premium
Company Announcements
Ono Pharmaceutical’s ONO-1110: A Promising Study for Social Anxiety Disorder
5M ago
ONO Pharmaceutical’s ONO-7428 Study: A New Hope for Solid Tumor Treatment
Premium
Company Announcements
ONO Pharmaceutical’s ONO-7428 Study: A New Hope for Solid Tumor Treatment
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100